Bruker stock kpis
Want to see BRKR full AI Analyst Report?
Capital Expenditure by Segment
Tracks where Bruker is investing in plant, equipment, and infrastructure across its segments, indicating commitments to capacity expansion, product development, or maintenance. Large or sustained capex in a segment can point to future growth opportunities but also raises cash needs and execution risk.
CapEx is clearly lumpy and project‑driven: large 2024–25 investments in BioSpin and CALID have mostly run their course (BioSpin spending falling to near‑zero by mid‑2026), which should free cash and support the margin and leverage improvements management is pushing. Meanwhile NANO and CALID still show episodic big spend consistent with the company’s semiconductor/deep‑tech push — capex likely precedes revenue because of long lead times — and declining BEST spend suggests lower priority or consolidation in that business.
BRKR Capital Expenditure by Segment
| Date | Corporate & Other | BSI BioSpin | BSI CALID | BSI NANO | BEST |
|---|---|---|---|---|---|
| Sep 30, 2026 | $2.10M | $0.00 | $0.00 | $6.70M | $2.10M |
| Jun 30, 2026 | $3.50M | $0.00 | $6.50M | $7.50M | $2.80M |
| Mar 31, 2026 | $2.30M | $2.40M | $6.70M | $4.90M | $1.60M |
| Dec 31, 2025 | $2.90M | $1.10M | $4.30M | $15.30M | $4.50M |
| Sep 30, 2025 | $1.50M | $4.80M | $7.10M | $3.10M | $2.10M |
| Jun 30, 2025 | $6.90M | $2.30M | $5.50M | $13.20M | $2.40M |
| Mar 31, 2025 | $4.70M | $3.20M | $8.40M | $4.90M | $4.80M |
| Dec 31, 2024 | $3.90M | $6.00M | $15.90M | $4.80M | $6.20M |
| Sep 30, 2024 | $4.20M | $13.40M | $6.50M | $4.30M | $4.20M |
| Jun 30, 2024 | $4.00M | $3.80M | $6.40M | $4.00M | $6.30M |
| Mar 31, 2024 | $2.70M | -$400.00K | $5.30M | $6.20M | $7.60M |

